The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

According to The Business Research Company’s Acne Drugs Global Market Report 2023, the global acne drugs market is projected to increase from $5.44 billion in 2022 to $5.74 billion in 2023, with a 5.6% CAGR. By 2027, it’s expected to reach $6.90 billion, growing at a 4.7% CAGR.

What was the major driver in the acne drugs market?
A rise in disposable income is a key acne drug market driver. Economic improvements raise wages, salaries, and healthcare spending. In the UK, the average household disposable income in 2020 was £30,800 ($37,830), up 2.3% from 2019. Increased disposable income and facial care product spending will drive the market ahead.

View More On The Acne Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

What was the key trend in the acne drugs market?
Combination therapy is the emerging trend in the acne drug market. It involves combining two drugs with distinct mechanisms of action, offering improved efficacy and adherence compared to monotherapy. Topical retinoids, which unclog pores, and antimicrobial drugs for infection are combined in acne treatment. Examples include Galderma’s Epiduo, Allergan’s Acanya, Medicis’ Ziana, and Atrix’s Benzamycin.

Which was the largest region in the acne drugs market?
North America was the largest region in the acne drugs market in 2022. The Middle East is expected to be the largest growing region in the global acne drugs market during the forecast period. The regions covered in the global acne drugs market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Who are the acne drugs market prominent players?
Major players in the acne drugs market are Allergan PLC., Galderma S.A., Valeant Pharmaceutical International Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services Inc., GlaxoSmithKline PLC., Bayer AG, Stiefel Laboratories Inc., Ranbaxy Laboratories Limited, Pfizer Inc., Sun Pharmaceutical Industries Limited, Mayne Pharma Group Limited, Mylan N.V., Cipher, Daiichi Sankyo Company, Ltd., Guthy-Renker LLC., Medicis Pharmaceutical Corporation, Foamix Pharmaceuticals, BioPharmX, In, Roche Holding AG, F. Hoffmann-la Roche Ltd., Anterios Inc., AndroScience, Oculus Innovative Sciences, Aqua Pharmaceuticals, Skinvisible Pharmaceuticals and Prestium Pharma Inc.

Key acne drugs market segments
The global acne drugs market is segmented –
1) By Type: Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs
2) By End User: Hospitals & Clinics, Pharmacies & Drug Stores, Ambulatory Surgical Centres
3) By Therapeutic Class: Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide

Request A Sample Of The Global Acne Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2412&type=smp

The Acne Drugs Global Market Report 2023  provides a comprehensive overview on the acne drugs market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Drugs For Erectile Dysfunction Global Market Report 2023
Photodynamic Therapy Global Market Report 2023
Anti Aging Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model